Ratanhiaphenol III from ratanhiae radix is a PTP1B inhibitor

Planta Medica

Volumn 78, Issue 7, 2012, Pages 678-681

  Heiss, Elke H ^a   Baumgartner, Lisa ^b   Schwaiger, Stefan ^b   Heredia, Raul Jimenez ^a   Atanasov, Atanas G ^a   Rollinger, Judith M ^b   Stuppner, Hermann ^b   Dirsch, Verena M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Krameria lappacea; Krameriaceae; PTP1B inhibition; Ratanhiae radix; ratanhiaphenol III

Indexed keywords

ANTIDIABETIC AGENT; INSULIN RECEPTOR; KL 6269; LIGNAN DERIVATIVE; PLANT EXTRACT; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; RATANHIAPHENOL III; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG ACTIVITY; ENZYME INHIBITION; GLUCOSE TRANSPORT; IC 50; IN VITRO STUDY; MEDICINAL PLANT; MOUSE; MUSCLE CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; RATANHIAE RADIX;

ANIMALS; BENZOFURANS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; KRAMERIACEAE; LIGNANS; METABOLIC SYNDROME X; MICE; MUSCLE CELLS; MUSCLE FIBERS, SKELETAL; PHYTOTHERAPY; PLANT PREPARATIONS; PLANT ROOTS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;

KRAMERIA LAPPACEA; KRAMERIACEAE; MURINAE;

EID: 84861099166     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1298242     Document Type: Article

References (10)

1. Unwin N, Whiting D, Gan D, Jacqmain O, Ghyoot G. IDF diabetes atlas. Brussels International Diabetes Federation 2009
2. Moller D E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001 414 821-827 (Pubitemid 34000786)
3. Zhang Z Y., Lee S Y. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Exp Opin Invest Drugs 2003 12 223-233
4. Bandyopadhyay D, Kusari A, Kenner K A., Liu F, Chernoff J, Gustafson T A., Kusari J. PTP1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem 1997 272 1639-1645 (Pubitemid 27043246)
5. Koren S, Fantus I G. Inhibition of the protein tyrosine phosphatase 1B: potential therapy for obesity, insulin resistance and type II diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2007 21 621-640 (Pubitemid 350185860)
6. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy A L., Normandin D, Cheng A, Himms-Hagen J, Chan C C., Ramachandran C, Gresser M J., Tremblay M L., Kennedy B. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase 1B gene. Science 1999 283 1544-1548
7. Baumgartner L, Sosa S, Atanasov A G., Bodensieck A, Fakhrudin N, Bauer J, Del Favero G, Ponti C, Heiss E H., Schwaiger S, Ladurner A, Widowitz U, Della Loggia R, Rollinger J M., Werz O, Bauer R, Dirsch V M., Tubaro A, Stuppner H. Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and proinflammatory mediators in vitro. J Nat Prod 2011 74 1779-1786
8. Dixit M, Saeed U, Kumar A, Siddigi M, Tamrakar A K., Srivastava A K., Goel A. Synthesis, molecular docking and PTP1B inhibitory activity of functionalized 4,5-dihydronaphtofurans and dibenzofurans. Med Chem 2010 20 3329-3337
9. Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J Y., Hu L H., Li J. Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and glucose uptake. Biochim Biophys Acta 2006 1760 1505-1512 (Pubitemid 44428024)
10. Baumgartner R R., Steinmann D, Heiss E H., Atanasov A G., Ganzera M, Stuppner H, Dirsch V M. Bioactivity-guided isolation of 1,2,3,4,6-penta- O -galloyl-D-glucopyranose from Paeonia lactiflora as PTP1B inhibitor. J Nat Prod 2010 73 1578-1581